UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023716
Receipt number R000027319
Scientific Title Influence of water content in skin and transepidermal water loss on residual drug amount in used Fentos tape
Date of disclosure of the study information 2016/08/22
Last modified on 2019/02/18 14:28:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Influence of water content in skin and transepidermal water loss on residual drug amount in used Fentos tape

Acronym

Influence of water content in skin and transepidermal water loss on residual drug amount in used Fentos tape

Scientific Title

Influence of water content in skin and transepidermal water loss on residual drug amount in used Fentos tape

Scientific Title:Acronym

Influence of water content in skin and transepidermal water loss on residual drug amount in used Fentos tape

Region

Japan


Condition

Condition

cancer pain

Classification by specialty

Not applicable

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

There were significant differences in the residual fentanyl citrate of used fentos tapes among patients.
The objective of this study was to elucidate whether the variation of fentanyl residual caused by the skin condition of patients.

Basic objectives2

Others

Basic objectives -Others

nothing

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

transepidermal water loss
water content in corner
residual of fentanyl citrate in used patches

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patients who are required for cancer pain control and are put on fentos tape

Key exclusion criteria

nothing

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Reiko Teraoka

Organization

Kobe Pharmaceutical University

Division name

Department of Pharmaceutical Technology

Zip code


Address

4-19-1, Motoyamakita-machi, Higashinada-ku, Kobe, 658-8558, Japan

TEL

078-441-7531

Email

teraoka@kobepharma-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Reiko Teraoka

Organization

Kobe Pharmaceutical University

Division name

Department of Pharmaceutical Technology

Zip code


Address

4-19-1, Motoyamakita-machi, Higashinada-ku, Kobe, 658-8558, Japan

TEL

078-441-7531

Homepage URL


Email

teraoka@kobepharma-u.ac.jp


Sponsor or person

Institute

Kobe Pharmaceutical University

Institute

Department

Personal name



Funding Source

Organization

Kobe Pharmaceutical University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Ashiya Municipal Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

市立芦屋病院、神戸薬科大学製剤学研究室


Other administrative information

Date of disclosure of the study information

2016 Year 08 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 07 Month 06 Day

Date of IRB


Anticipated trial start date

2016 Year 08 Month 22 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

nothing


Management information

Registered date

2016 Year 08 Month 22 Day

Last modified on

2019 Year 02 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027319


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name